Allianz Asset Management GmbH Purchases 117,442 Shares of The Clorox Company $CLX

Allianz Asset Management GmbH boosted its position in shares of The Clorox Company (NYSE:CLX) by 510.5% in the second quarter, Holdings Channel.com reports. The institutional investor owned 140,449 shares of the company’s stock after acquiring an additional 117,442 shares during the period. Allianz Asset Management GmbH’s holdings in Clorox were worth $16,864,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of CLX. Hsbc Holdings PLC lifted its stake in shares of Clorox by 118.8% in the 1st quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company’s stock valued at $159,699,000 after purchasing an additional 589,544 shares during the last quarter. Robeco Institutional Asset Management B.V. lifted its stake in shares of Clorox by 101.8% in the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 1,083,723 shares of the company’s stock valued at $130,123,000 after purchasing an additional 546,761 shares during the last quarter. KBC Group NV lifted its stake in shares of Clorox by 688.7% in the 1st quarter. KBC Group NV now owns 587,679 shares of the company’s stock valued at $86,535,000 after purchasing an additional 513,171 shares during the last quarter. AQR Capital Management LLC lifted its stake in shares of Clorox by 412.1% in the 1st quarter. AQR Capital Management LLC now owns 598,758 shares of the company’s stock valued at $88,167,000 after purchasing an additional 481,846 shares during the last quarter. Finally, Goldman Sachs Group Inc. lifted its stake in shares of Clorox by 147.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 707,005 shares of the company’s stock valued at $104,107,000 after purchasing an additional 421,453 shares during the last quarter. 78.53% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This trade represents a 21.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.63% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on CLX shares. Barclays lowered their price objective on Clorox from $118.00 to $112.00 and set an “underweight” rating for the company in a research note on Tuesday, September 30th. Zacks Research upgraded Clorox from a “strong sell” rating to a “hold” rating in a report on Monday, September 29th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a report on Tuesday, October 14th. Citigroup reduced their price target on Clorox from $135.00 to $130.00 and set a “neutral” rating on the stock in a report on Wednesday, October 8th. Finally, Wells Fargo & Company reduced their price target on Clorox from $130.00 to $125.00 and set an “equal weight” rating on the stock in a report on Thursday, September 25th. One equities research analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have given a Sell rating to the company. According to MarketBeat.com, Clorox presently has an average rating of “Reduce” and an average price target of $130.20.

Clorox Trading Down 0.1%

CLX opened at $119.60 on Tuesday. The stock’s fifty day moving average is $121.56 and its two-hundred day moving average is $127.42. The company has a market capitalization of $14.56 billion, a P/E ratio of 18.34, a PEG ratio of 0.99 and a beta of 0.52. The Clorox Company has a 52 week low of $116.53 and a 52 week high of $171.37. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15.

Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping the consensus estimate of $2.24 by $0.63. The company had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.Clorox’s quarterly revenue was up 4.5% on a year-over-year basis. During the same period last year, the business posted $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be issued a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a yield of 4.1%. The ex-dividend date is Wednesday, October 22nd. Clorox’s dividend payout ratio (DPR) is presently 76.07%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.